SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unjha Formulations - Quaterly Results

17 May 2024 Evaluate
The turnover zoomed to Rs. 44.39 millions, up 56.14% for the March 2024 quarter as against Rs. 28.43 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -1.76 millions as compared to Net Loss of Rs. -2.24 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 improved to 0.71% as compared to -1.11% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 44.39 28.43 56.14 185.08 131.85 40.37 185.08 131.85 40.37
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 0.71 -1.11 -163.96 5.89 4.63 27.21 5.89 4.63 27.21
Interest 0.50 0.47 6.38 0.56 0.58 -3.45 0.56 0.58 -3.45
PBDT 0.21 -1.58 -113.29 5.33 4.05 31.60 5.33 4.05 31.60
Depreciation 0.23 0.19 21.05 0.81 0.77 5.19 0.81 0.77 5.19
PBT -0.02 -1.77 -98.87 4.52 3.28 37.80 4.52 3.28 37.80
TAX 1.74 0.47 270.21 1.74 0.47 270.21 1.74 0.47 270.21
Deferred Tax 0.06 0.47 -87.23 0.06 0.00 0.00 0.06 0.00 0.00
PAT -1.76 -2.24 -21.43 2.78 2.81 -1.07 2.78 2.81 -1.07
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 1.60 -3.90 -140.97 3.18 3.51 -9.37 3.18 3.51 -9.37

Unjha Formulations Share Price

20.95 -0.05 (-0.24%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×